Applied Therapeutics (APLT) announced the following leadership changes, effective immediately: John H. Johnson, a recognized leader in the pharmaceutical and biotechnology industry, has been named Executive Chairman; Dr. Shoshana Shendelman has stepped down as Chair and CEO; and Les Funtleyder, Applied Therapeutics’ Chief Financial Officer, has been named Interim Chief Executive Officer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APLT:
- Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP
- Edgewise should be bought on weakness as ARCH not likely FDA focus, says Truist
- Applied Therapeutics Faces FDA Challenges with Govorestat
- Applied Therapeutics downgraded to Neutral from Buy at UBS
- Applied Therapeutics price target lowered to $5 from $14 at Baird